[SRNE] QoQ Quarter Result on 30-Jun-2017 [#Q2]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
09-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- 38.49%
YoY- 68.44%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 6,246 20,407 121,910 4,665 4,874 4,019 2,243 98.05%
PBT -33,574 -38,001 94,953 -16,137 -25,499 -12,724 14,031 -
Tax -948 -90,424 57,480 -1,398 -1,696 -701 -195 187.25%
NP -32,574 12,425 33,959 -14,187 -23,064 -11,957 14,373 -
Tax Rate - - -60.54% - - - 1.39% -
Total Cost 38,820 7,982 87,951 18,852 27,938 15,976 -12,130 -
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin -521.52 60.89 27.86 -304.12 -473.20 -297.51 640.79 -
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
EPS -0.38 0.15 0.44 -0.20 -0.45 -0.23 0.22 -
EPS Diluted -0.38 0.15 0.44 -0.20 -0.45 -0.23 0.22 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.